Compare BHM & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHM | BEAT |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 44.8M |
| IPO Year | 2022 | N/A |
| Metric | BHM | BEAT |
|---|---|---|
| Price | $11.43 | $1.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $15.00 | $5.63 |
| AVG Volume (30 Days) | 11.3K | ★ 839.3K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 4.40% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,734,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $260.78 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.88 | N/A |
| 52 Week Low | $8.05 | $0.54 |
| 52 Week High | $14.81 | $4.00 |
| Indicator | BHM | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 54.80 | 43.78 |
| Support Level | $10.90 | $1.17 |
| Resistance Level | $12.11 | $1.35 |
| Average True Range (ATR) | 0.77 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 54.63 | 34.29 |
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.